Alcohol Dependency Study: Combining Medication Treatment for Alcoholism

Status unconfirmed · Phase 2 · Has a placebo group

Conditions studied: Alcoholism

In brief

The purpose of this study is to learn whether ondansetron and topiramate either alone or in combination is safe and effective in the treatment of alcohol dependence. This 13 week out-patient clinical trial is randomized, double-blind, and placebo-controlled. There are post-study follow up visits 1, 2 and 3 months after the end of the study. Participants will receive ondansetron and topiramate either alone or in combination or a placebo coupled with psychotherapy.

Key facts

Study ID

NCT00006205

Run by

Bankole Johnson

People needed

320

Starts

2005-03-01

Expected to finish

2013-12-01

Last updated by the study team

2013-03-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Current diagnosis of alcohol dependence and drinking greater than or equal to 14 alcohol drinks/week for women and greater than or equal to 21 alcohol drinks/week for men in the last 30 days.
• Provide a written, informed consent.
• Good physical health and must weigh within at least 40 kg and no more than 140 kg.
• Literate in English and able to read, understand, follow instructions, and complete questionnaires accurately.
• Willingness to participate in behavioral treatments for alcoholism.
• Provide evidence of stable residence in the last month prior to enrollment in the study and have no plans to move during the next three months.

You may not qualify if…

• Please contact site for additional information

Where it is running

• University of Virginia Center for Addiction Research and Education — Charlottesville, Virginia, United States (enrolling)
• University of Virginia Center for Addiction Research and Education — Richmond, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.